Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusagro's net profit decreased by 68% in the first quarter

5/13/24 AGRO

IKS 5 Corporate Center LLC starts transformation into a PJSC

5/8/24 X5

Tinkoff shareholders approve additional share issue for the purchase of Rosbank

5/8/24 ROSB

Tinkoff shareholders approved the additional share issue

5/8/24 T

Board of Directors of Rosseti Center and Volga Region recommended dividends

5/8/24 MRKP

Super Lents will be cleaned by Chinese Pudu CC1 robots

5/8/24 LENT

Samokat started working in Neftekamsk

5/8/24 SBER

Board of Directors of Korshynov Mining Plant recommended that dividends be paid for 2023

5/8/24 KOGK

Largest export market of Phosagro became Latin America

5/8/24 PHOR

Board of Directors of IMCB recommended that dividends be paid for 2023

5/7/24 GEMA